SKT-M-26

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSKT-M-26
Drug Alias Namemethylripariochromene (Toyama)SKT-M-26
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertensionCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A